Treatment of lichen planopilaris with the TYK-2 inhibitor deucravacitinib

Affiliations

• ¹ Department of Dermatology, Huashan Hospital, Shanghai Institute of Dermatology, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China.
• ² Department of Dermatology, Jing'an District Central Hospital, Shanghai, China.
• ³ Department of Dermatology, Huashan Hospital, Shanghai Institute of Dermatology, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China. Electronic address: wuwenyu@huashan.org.cn.
• ⁴ Department of Dermatology, Huashan Hospital, Shanghai Institute of Dermatology, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China; Department of Dermatology, Jing'an District Central Hospital, Shanghai, China. Electronic address: jinranlin@fudan.edu.cn.
• ⁵ Department of Dermatology, Huashan Hospital, Shanghai Institute of Dermatology, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China; Department of Dermatology, Jing'an District Central Hospital, Shanghai, China; Academy for Engineering and Technology, Fudan University, Shanghai, China. Electronic address: blueqiong1972@163.com.